Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Tolerability of Intravitreal VEGF Trap Formulations in Subjects With Neovacular AMD

This study has been completed.
Information provided by:
Regeneron Pharmaceuticals Identifier:
First received: October 2, 2006
Last updated: April 20, 2011
Last verified: April 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2008
  Primary Completion Date: September 2007 (Final data collection date for primary outcome measure)